HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Walker, F. J. Articles by Esmon, C. T. Search for Related Content PubMed PubMed Citation Articles by Walker, F. J. Articles by Esmon, C. T. Social Bookmarking                      What's this?

JBC, Vol. 254, Issue 13, 5618-5622, Jul, 1979

The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin III

F. J. Walker and C. T. Esmon

The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin III has been studied. Fragment 2 was found to slow the rate of inhibition of thrombin by antithrombin III about 3-fold. The effect of prothrombin fragment 2 on antithrombin III inhibition was examined by comparing its action in the presence of either thrombin or meizothrombin (des fragment 1). The second order rate constants for antithrombin III inhibition of thrombin with saturating fragment 2 and antithrombin III inhibition of meizothrombin (des fragment 1) were the same. Prothrombin fragment 2 had no effect on either antithrombin III inhibition of meizothrombin (des fragment 1) or Factor Xa. The effect of the fragment on the reaction mechanism of thrombin inhibition was evaluated to see if the fragment altered binding of antithrombin III to thrombin or inhibited the formation of the covalent complex. The fragment was found to have no inhibitory effect on the rate of covalent complex formation, indicating that the protective effect of the fragment is by inhibiting binding of antithrombin III to thrombin. These data suggest that prothrombin fragment 2 may be an important factor in controlling the localization of clot formation by regulating the interaction between thrombin and antithrombin III.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. M. Verhamme, S. T. Olson, D. M. Tollefsen, and P. E. Bock Binding of Exosite Ligands to Human Thrombin. RE-EVALUATION OF ALLOSTERIC LINKAGE BETWEEN THROMBIN EXOSITES I AND II J. Biol. Chem., February 22, 2002; 277(9): 6788 - 6798. [Abstract] [Full Text] [PDF]

				R. Q. Monteiro, P. E. Bock, M. L. Bianconi, and R. B. Zingali Characterization of bothrojaracin interaction with human prothrombin Protein Sci., September 1, 2001; 10(9): 1897 - 1904. [Abstract] [Full Text] [PDF]

				P. C. Y. Liaw, J. C. Fredenburgh, A. R. Stafford, A. Tulinsky, R. C. Austin, and J. I. Weitz Localization of the Thrombin-binding Domain on Prothrombin Fragment 2 J. Biol. Chem., April 10, 1998; 273(15): 8932 - 8939. [Abstract] [Full Text] [PDF]

				J. C. Fredenburgh, A. R. Stafford, and J. I. Weitz Evidence for Allosteric Linkage between Exosites 1 and 2 of Thrombin J. Biol. Chem., October 10, 1997; 272(41): 25493 - 25499. [Abstract] [Full Text] [PDF]

				H. C.F. Cote, L. Bajzar, W. K. Stevens, J. A. Samis, J. Morser, R. T.A. MacGillivray, and M. E. Nesheim Functional Characterization of Recombinant Human Meizothrombin and Meizothrombin(desF1). THROMBOMODULIN-DEPENDENT ACTIVATION OF PROTEIN C AND THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI), PLATELET AGGREGATION, ANTITHROMBIN-III INHIBITION J. Biol. Chem., March 7, 1997; 272(10): 6194 - 6200. [Abstract] [Full Text] [PDF]

				A. R. Rezaie and C. T. Esmon Contribution of Residue 192 in Factor Xa to Enzyme Specificity and Function J. Biol. Chem., July 7, 1995; 270(27): 16176 - 16181. [Abstract] [Full Text] [PDF]